Design
Other
Authors
Loading...
May explain variable clopidogrel response; leaves open whether MDR1 genotyping or P-gp modulation improves outcomes.
P-glycoprotein efflux and the MDR1 C3435T genotype diminish clopidogrel absorption and active metabolite formation.
Taubert et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: